| (84) |
Designated Contracting States: |
|
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL
NO PL PT RO RS SE SI SK SM TR |
| (30) |
Priority: |
07.01.2015 EP 15290003
|
| (43) |
Date of publication of application: |
|
15.11.2017 Bulletin 2017/46 |
| (60) |
Divisional application: |
|
20202446.9 / 3828198 |
| (73) |
Proprietors: |
|
- Pfizer Inc.
New York, NY 10017 (US)
- INSERM - Institut National de la Santé et de la
Recherche Médicale
75013 Paris (FR)
- Université Côte d'Azur
06100 Nice Cedex 2 (FR)
|
|
| (72) |
Inventors: |
|
- GOUZE, Elvire
06410 Biot (FR)
- GARCIA, Stéphanie
06200 Nice (FR)
|
| (74) |
Representative: Zwicker, Jörk |
|
ZSP Patentanwälte PartG mbB
Hansastraße 32
80686 München
80686 München (DE) |
| (56) |
References cited: :
WO-A1-2014/111467
WO-A2-2008/133873
US-A1- 2003 235 589
|
WO-A2-2007/014123
WO-A2-2011/084711
|
|
| |
|
|
- S. GARCIA ET AL: "Postnatal Soluble FGFR3 Therapy Rescues Achondroplasia Symptoms
and Restores Bone Growth in Mice", SCIENCE TRANSLATIONAL MEDICINE, vol. 5, no. 203,
18 September 2013 (2013-09-18), XP055194295, ISSN: 1946-6234, DOI: 10.1126/scitranslmed.3006247
cited in the application
- F. H. CHEN ET AL: "Interaction of Cartilage Oligomeric Matrix Protein/Thrombospondin
5 with Aggrecan", JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 282, no. 34, 22 June 2007
(2007-06-22), pages 24591-24598, XP055194302, ISSN: 0021-9258, DOI: 10.1074/jbc.M611390200
- D LI ET AL: "A novel decoy receptor fusion protein for FGF-2 potently inhibits tumour
growth", BRITISH JOURNAL OF CANCER, vol. 111, no. 1, 29 May 2014 (2014-05-29), pages
68-77, XP055160715, ISSN: 0007-0920, DOI: 10.1038/bjc.2014.282
- SU-JEONG HWANG ET AL: "High-level Expression and Purification of a Designed Angiopoietin-1
Chimeric Protein, COMP-Ang1, Produced in Chinese Hamster Ovary Cells", JOURNAL OF
PROTEIN CHEMISTRY, KLUWER ACADEMIC PUBLISHERS-PLENUM PUBLISHERS, NE, vol. 27, no.
5, 9 May 2008 (2008-05-09), pages 319-326, XP019609300, ISSN: 1573-4943
|
|
